Vous êtes ici : Accueil / Valorisation / Publications / 2020

Infos pratiques

Organigramme
Contacts
  • Directeur :

        Pr Eric DELAPORTE

  • Directeur Adjoint :

        Bernard TAVERNE

Accès à la Délégation Régionale IRD-Occitanie (Montpellier)

2020

Tram J., Le Baccon-Sollier P., Bolloré K., Ducos J., Mondain A.-M., Pastor P., Pageaux G.-P., Makinson A., Van de Perre P., et Tuaillon E.,
RNA testing for the diagnosis of acute hepatitis A during the 2017 outbreak in France,
J. Viral Hepat., janv. 2020. doi: 10.1111/jvh.13255.

Barraud O., Robert A., Laval L., Ruimy R., Morquin D., Boyer L., et Lamy B.,
It takes two to tango: two Aeromonas isolates combine virulence and multidrug resistance in flap infection following leech therapy,
Clin. Microbiol. Infect., janv. 2020. doi: 10.1016/j.cmi.2019.12.021.

Liégeois F., Boyer S., Eymard-Duvernay S., Carrieri P., Kouanfack C., Domyeum J., Maradan G., Ducos J., Mpoudi-Ngolé E., Spire B., Delaporte E., Kuaban C., Vidal L., Laurent C., et EVOLCAM study group,
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM),
BMC Infect. Dis., vol. 20, no 1, p. 49, janv. 2020. doi: 10.1186/s12879-020-4784-7.

Poizot-Martin I., Obry-Roguet V., Duvivier C., Lions C., Huleux T., Jacomet C., Ferry T., Cheret A., Allavena C., Bani-Sadr F., Palich R., Cabié A., Fresard A., Pugliese P., Delobel P., Lamaury I., Hustache-Mathieu L., Brégigeon S., Makinson A., Rey D., et Dat’AIDS study group,
Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015,
J Eur Acad Dermatol Venereol, janv. 2020. doi: 10.1111/jdv.16204.

Navarro M., Camprubí D., Requena-Méndez A., Buonfrate D., Giorli G., Kamgno J., Gardon J., Boussinesq M., Muñoz J., et Krolewiecki A.,
Safety of high-dose ivermectin: a systematic review and meta-analysis,
J. Antimicrob. Chemother., janv. 2020. doi: 10.1093/jac/dkz524.

Yakhelef N., Audibert M., Ferlazzo G., Sitienei J., Wanjala S., Varaine F., Bonnet M., et Huerga H.,
Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis,
PLoS ONE, vol. 15, no 1, p. e0227138, 2020. doi: 10.1371/journal.pone.0227138.

Atwine D., Baudin E., Gelé T., Muyindike W., Mworozi K., Kyohairwe R., Kananura K., Orikiriza P., Nyehangane D., K T Nanjebe D., Furlan V., Verstuyft C., Barrail-Tran A., Taburet A.-M., Bonnet M., et ANRS 12292 Rifavirenz study group,
Effect of high-dose rifampicin on efavirenz pharmacokinetics: drug-drug interaction randomized trial,
J. Antimicrob. Chemother., janv. 2020. doi: 10.1093/jac/dkz557.

Ayouba A. et Peeters M.,
Reply to Zhang et al,
J. Infect. Dis., févr. 2020. doi: 10.1093/infdis/jiaa041.

Bonnet M.,
Xpert MTB/RIF Ultra: what is the real impact?,
Lancet Respir Med, févr. 2020. doi: 10.1016/S2213-2600(20)30050-3.

Tuaillon E., Kania D., Pisoni A., Bollore K., Taieb F., Ontsira Ngoyi E. N., Schaub R., Plantier J.-C., Makinson A., et Van de Perre P.,
Dried Blood Spot Tests for the Diagnosis and Therapeutic Monitoring of HIV and Viral Hepatitis B and C,
Front Microbiol, vol. 11, p. 373, 2020. doi: 10.3389/fmicb.2020.00373.

Coulaud P.-J., Sagaon-Teyssier L., Mimi M., M’madi Mrenda B., Maradan G., Mora M., Bourrelly M., Keita B. D., Keita A. A., Anoma C., Babo Yoro S.-A., Dah T. T. E., Coulibaly C., Mensah E., Agbomadji S., Bernier A., Couderc C., Laurent C., Spire B., et CohMSM Study Group,
Combined Sexual Behavioral Profiles in HIV-Seronegative Men Who have Sex with Men in West Africa (CohMSM ANRS 12324-Expertise France),
Arch Sex Behav, vol. 49, no 1, p. 331‑345, 2020. doi: 10.1007/s10508-019-01513-z.

Martinez L., Cords O., Horsburgh C. R., Andrews J. R., et Pediatric TB Contact Studies Consortium,
The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis,
Lancet, vol. 395, no 10228, p. 973‑984, 21 2020. doi: 10.1016/S0140-6736(20)30166-5.

Lienhardt C., Nunn A., Chaisson R., Vernon A. A., Zignol M., Nahid P., Delaporte E., et Kasaeva T.,
Advances in clinical trial design: Weaving tomorrow’s TB treatments,
PLoS Med., vol. 17, no 2, p. e1003059, févr. 2020. doi: 10.1371/journal.pmed.1003059.

Coulaud P.-J., Sagaon-Teyssier L., Mimi M., Maradan G., Mora M., Bourrelly M., Dembélé Keita B., Keita A. A., Anoma C., Yoro S.-A. B., Dah E. T. T., Coulibaly C., Mensah E., Agbomadji S., Palvadeau P., Bernier A., Rojas Castro D., Couderc C., Laurent C., Spire B., et CohMSM Study Group,
Changes in risky sexual behaviours among West African MSM enrolled in a quarterly HIV testing and counselling prevention programme (CohMSM ANRS 12324 - Expertise France),
Sex Transm Infect, vol. 96, no 2, p. 115‑120, mars 2020. doi: 10.1136/sextrans-2018-053892.

For the 2-Lady Group, Boyer S., Nishimwe M. L., Sagaon-Teyssier L., March L., Koulla-Shiro S., Bousmah M.-Q., Toby R., Mpoudi-Etame M. P., Ngom Gueye N. F., Sawadogo A., Kouanfack C., Ciaffi L., Spire B., et Delaporte E.,
Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa,
PharmacoEconomics Open, vol. 4, no 1, p. 45‑60, mars 2020. doi: 10.1007/s41669-019-0157-9.

Sams K., Desclaux A., et Sow S.,
They’ll inject you and you’ll die : from medication non-compliance to acceptance in Guinea’s Ebola treatment units,
Anthropol Med, vol. 27, no 1, p. 1‑16, mars 2020. doi: 10.1080/13648470.2019.1615749.

Frange P., Tubiana R., Sibiude J., Canestri A., Arvieux C., Brunet-Cartier C., Cotte L., Reynes J., Mandelbrot L., Warszawski J., Le Chenadec J., et ANRS EPF CO1/CO11 Study Group,
Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?,
J. Antimicrob. Chemother., mars 2020. doi: 10.1093/jac/dkaa017.

Jacquet J.-M., Donnadieu-Rigole H., Peries M., Makinson A., Nagot N., Reynes J., Peyriere H., et MesConsos study group name,
Implementing screening, brief intervention and referral to treatment in a French cohort of people living with HIV: a pilot study,
HIV Med., vol. 20, no 4, p. 286‑290, 2019. doi: 10.1111/hiv.12709.

Etard J.-F., Vanhems P., Atlani-Duault L., et Ecochard R.,
Potential lethal outbreak of coronavirus disease (COVID-19) among the elderly in retirement homes and long-term facilities, France, March 2020,
Euro Surveill., vol. 25, no 15, 2020. doi: 10.2807/1560-7917.ES.2020.25.15.2000448.

De Baetselier I., Vuylsteke B., Yaya I., Dagnra A., Diandé S., Mensah E., Dah E., Anoma C., Koné A., Fayé-Ketté H., Yeo A., Keita B. D., Laurent C., Crucitti T., et CohMSM-PrEP pooling study group,
To pool or not to pool samples for Sexually Transmitted Infections detection in Men who have Sex with Men? An evaluation of a new pooling method using the GeneXpert instrument in West-Africa,
Sex Transm Dis, avr. 2020. doi: 10.1097/OLQ.0000000000001191.

Campillo J. T., Chesnais C. B., Pion S. D. S., Gardon J., Kamgno J., et Boussinesq M.,
Individuals living in an onchocerciasis focus and treated three-monthly with ivermectin develop fewer new onchocercal nodules than individuals treated annually,
Parasit Vectors, vol. 13, no 1, p. 258, mai 2020. doi: 10.1186/s13071-020-04126-x.

Edoul G., Chia J. E., Vidal N., Guichet E., Montavon C., Delaporte E., Mpoudi Ngole E., Ayouba A., et Peeters M.,
High HIV burden and recent transmission chains in rural forest areas in southern Cameroon, where ancestors of HIV-1 have been identified in ape populations,
Infect. Genet. Evol., vol. 84, p. 104358, mai 2020. doi: 10.1016/j.meegid.2020.104358.

Boussinesq M., Enyong P., Chounna-Ndongmo P., Njouendou A.-J., Pion S. D., Rech A., Roberge C., Gaudriault G., et Wanji S.,
Effects of an injectable long-acting formulation of ivermectin on Onchocerca ochengi in zebu cattle,
Parasite, vol. 27, p. 36, 2020. doi: 10.1051/parasite/2020036.

Lavole A., Greillier L., Mazières J., Monnet I., Kiakouama-Maleka L., Quantin X., Spano J. P., Herve L., Fraisse P., Janicot H., Audigier-Valette C., Langlais A., Morin F., Makinson A., Cadranel J., et Written on behalf of the French Cooperative Thoracic Intergroup (IFCT),
First-Line Carboplatin Plus Pemetrexed with Pemetrexed Maintenance in HIV+ Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: The Phase II IFCT-1001 CHIVA Trial,
Eur. Respir. J., mai 2020. doi: 10.1183/13993003.02066-2019.

Gobbi F., Buonfrate D., Boussinesq M., Chesnais C., Pion S., Silva R., Moro L., Rodari P., Tamarozzi F., Biamonte M., et Bisoffi Z.,
Performance of two serodiagnostic tests for loiasis in a Non-Endemic area,
PLoS Negl Trop Dis, vol. 14, no 5, p. e0008187, mai 2020. doi: 10.1371/journal.pntd.0008187.

Chesnais C. B., Bizet C., Campillo J. T., Njamnshi W. Y., Bopda J., Nwane P., Pion S. D., Njamnshi A. K., et Boussinesq M.,
A Second Population-Based Cohort Study in Cameroon Confirms the Temporal Relationship Between Onchocerciasis and Epilepsy,
Open Forum Infect Dis, vol. 7, no 6, p. ofaa206, juin 2020. doi: 10.1093/ofid/ofaa206.

Pion S. D. S., Chesnais C. B., Awaca-Uvon N. P., Vlaminck J., Abdou A., Kunyu-Shako B., Kuyangisa Simuna G., Tambwe J.-P., Weil G. J., et Boussinesq M.,
The impact of four years of semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: A community-based study in the Democratic Republic of the Congo,
PLoS Negl Trop Dis, vol. 14, no 6, p. e0008322, juin 2020. doi: 10.1371/journal.pntd.0008322.

Pion S. D. et Chesnais C. B.
Uncovering the burden of loiasis: first estimates from Gabon,
Lancet Infect Dis, juin 2020. doi: 10.1016/S1473-3099(20)30324-8.

Gaillard C. M., Pion S. D., Hamou H., Sirima C., Bizet C., Lemarcis T., Rodrigues J., Esteban A., Peeters M., Mpoudi Ngole E., Mombo I., Liégeois F., Martin C., Boussinesq M., et Locatelli S.,
Detection of DNA of filariae closely related to Mansonella perstans in faecal samples from wild non-human primates from Cameroon and Gabon,
Parasit Vectors, vol. 13, no 1, p. 313, juin 2020. doi: 10.1186/s13071-020-04184-1.

Cogliati M., Roger F., Meyer W., Robert V., et Bertout S.,
New multilocus sequence typing primers to enable genotyping of AD hybrids within the Cryptococcus neoformans species complex,
Med. Mycol., juin 2020. doi: 10.1093/mmy/myaa047.

Kamgno J., Tchatchueng-Mbougua J. B., Nana-Djeunga H. C., Esso L., Zouré H. G., Mackenzie C. D., et Boussinesq M.,
Community-based door to door census of suspected people living with epilepsy: empowering community drug distributors to improve the provision of care to rural communities in Cameroon,
BMC Public Health, vol. 20, no 1, p. 871, juin 2020. doi: 10.1186/s12889-020-08997-8.

Pion S. D., Nana-Djeunga H., Niamsi-Emalio Y., Chesnais C. B., Deléglise H., Mackenzie C., Stolk W., Fletcher D. A., Klion A. D., Nutman T. B., Boussinesq M., et Kamgno J.,
Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study,
Lancet Infect Dis, vol. 20, no 1, p. 102‑109, 2020. doi: 10.1016/S1473-3099(19)30554-7.

Ayouba A., Thaurignac G., Morquin D., Tuaillon E., Raulino R., Nkuba A., Lacroix A., Vidal N., Foulongne V., Le Moing V., Reynes J., Delaporte E., et Peeters M.,
Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV,
Journal of Clinical Virology, vol. 129, p. 104521, août 2020. doi: 10.1016/j.jcv.2020.104521.

Tchiakpe E., Keke R. K., Vidal N., Ahoussinou C., Sekpe O., Dagba H. G., Gbaguidi E., Tonoukouen C., Afangnihoun A., Bachabi M., Gangbo F. A., Diop-Ndiaye H., et Toure-Kane C.,
Moderate rate of transmitted resistance mutations to antiretrovirals and genetic diversity in newly HIV-1 patients diagnosed in Benin,
BMC Research Notes, vol. 13, no 1, p. 314, juill. 2020. doi: 10.1186/s13104-020-05151-w.

Clark E., Guilpain P., Filip I. L., Pansu N., Le Bihan C., Cartron G., Tchernonog E., Roubille C., Morquin D., Makinson A., Tuaillon E., et Le Moing V.,
Convalescent plasma for persisting COVID-19 following therapeutic lymphocyte depletion: a report of rapid recovery,
Br. J. Haematol., juin 2020. doi: 10.1111/bjh.16981.

Blanc F.-X., Badje A. D., Bonnet M., Gabillard D., Messou E., Muzoora C., Samreth S., Nguyen B. D., Borand L., Domergue A., Rapoud D., Natukunda N., Thai S., Juchet S., Eholié S. P., Lawn S. D., Domoua S. K., Anglaret X., Laureillard D., et STATIS ANRS 12290 Trial Team,
Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults,
N. Engl. J. Med., vol. 382, no 25, p. 2397‑2410, 18 2020. doi: 10.1056/NEJMoa1910708.